-
Who we are
Who we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
What we do
What we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Latest quarterly earnings
Latest investor presentation
Latest clinical presentation
Latest publications
Annual report
NASDAQ:NVAX
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Past Events
Filter
Filter
Clear filterWednesday, January 13, 2016
11:30am - 11:59pm PST
Thursday, December 3, 2015
Tuesday, December 1, 2015
2:00pm EST
Tuesday, November 17, 2015
4:30pm EST
Monday, November 9, 2015
8:00am EST
Tuesday, September 29, 2015
1:30pm EDT
Tuesday, September 29, 2015
9:00am EDT
Wednesday, August 12, 2015
12:45pm EDT
Monday, August 10, 2015
4:45pm EDT
Thursday, May 7, 2015
4:30pm EDT
Wednesday, April 15, 2015
8:00am EDT
Sunday, February 15, 2015
4:30pm EST
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
![Graph icon](/sites/default/files/images/Investors-Abstract.png)